MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds Aug 30, 2018 07:00 am | Patricia Inacio, PhD

Cystic Fibrosis Weekly Update

Contents:

• MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds
• A Plan for a Healthier Season in Parenting
• Measuring D-Lactate in Blood May Indicate Pancreatic Insufficiency in CF Patients, Study Suggests
• Disease Fatigue Is Not the Same as Laziness
• CF Patients’ Response to Kalydeco Impaired by Single Variants in SLC26A9 Gene, Study Reports

MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds

Aug 30, 2018 07:00 am | Patricia Inacio, PhD

Up to one month of treatment with inhaled vancomycin, the antibiotic of choice for treating most methicillin-resistant Staphylococcus aureus (MRSA) infections, together with a combination of oral and topical antibiotics, failed to clear infection in cystic fibrosis (CF) patients at better rates than the antibiotic combination alone, results from a Phase 2 clinical trial show. The study “Eradication […] The post MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Findsappeared first on Cystic Fibrosis News Today.

Read More Recent News Firms Will Test Digital Platform to Help Patients Manage CF-Related Diabetes Orkambi Not Seen to Significantly Improve Blood Glucose Levels in CF Patients in Small Study I Have Cystic Fibrosis, and CF Has Me ELITechGroup Launches Improved Macroduct Sweat Test for Cystic Fibrosis Diagnosis Who Runs the Ward? Women.